Novo Nordisk Pharmaceuticals Limited

About Novo Nordisk 

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries.
Novo Nordisk's B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

Our business philosophy

The Triple Bottom Line - our way of doing business
We believe that a healthy economy, environment and society are fundamental to long-term business success. This is why we manage our business in accordance with the Triple Bottom Line business principle and pursue business solutions that maximise value to our stakeholders as well as our shareholders.

In practice, this means that any decision should always seek to combine three considerations: is it financially, socially and environmentally responsible? This way, we continuously optimise our business performance and enhance our contribution to the societies we operate in.

 Careers

We are world leaders in diabetes care with a growing business in other treatment areas like haemophilia and chronic inflammation. We are more than 33,000 employees in 75 countries. Join us!

For more information on roles within this company please contact your Novo Nordisk Account Manager